Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intravascular malignant lymphomatosis]

A Koto1

  • 1Department of Neurology, School of Medicine, Keio University.

Rinsho Shinkeigaku = Clinical Neurology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calbindin-D28k in cerebrovascular extrinsic innervation system of the rat.

Autonomic neuroscience : basic & clinical·2000
Same author

Portal systemic encephalopathy presenting with dressing and constructional apraxia.

Internal medicine (Tokyo, Japan)·2000
Same author

Hyalinosis cutis et mucosae: a case report.

Journal of neurology·2000
Same author

POEMS syndrome with necrotizing vasculitis: a novel feature of vascular abnormalities.

Neurology·2000
Same author

Characteristic form of standing up from squatting in Miyoshi's distal muscular dystrophy.

Clinical neurology and neurosurgery·2000
Same author

Pathologic findings of silent hyperintense white matter lesions on MRI.

Journal of the neurological sciences·1999

Intravascular malignant lymphomatosis (IML) presents with neurological symptoms and elevated inflammatory markers, necessitating early histological diagnosis. Prompt chemotherapy offers hope for a cure for this rare lymphoma.

Area of Science:

  • Neurology
  • Hematology
  • Oncology

Background:

  • Intravascular malignant lymphomatosis (IML) is a rare condition.
  • It often presents with neurological symptoms mimicking cerebrovascular diseases.

Observation:

  • IML commonly manifests as hemiparesis, progressive dementia, and consciousness disturbances.
  • Spinal cord involvement leading to paraparesis and dysuria can occur.
  • Elevated erythrocyte sedimentation rate, C-reactive protein, lactate dehydrogenase, and cerebrospinal fluid protein are frequent findings.

Findings:

  • Diagnosis requires histological confirmation, with skin, muscle, or organ biopsies (kidney, adrenals, lungs, liver) being crucial.
  • Adrenal gland involvement may be indicated by swelling on CT or MRI scans.

Related Experiment Videos

Implications:

  • Early diagnosis and treatment initiation are critical for improving patient outcomes.
  • While chemotherapy is indicated, its efficacy is often limited by diagnostic delays.
  • Future research focusing on early combined chemotherapeutic strategies may lead to a cure for IML.